Updates from The Motley Fool

Latest updates on Neurocrine Biosciences, Inc. from Fool.com.


Stock Performance

NBIX vs. S&P 500 | 2 Year Performance
NBIX 1-Day Stock Chart
NBIX 5-Day Stock Chart
NBIX 1-Month Stock Chart
NBIX 3-Month Stock Chart
NBIX 6-Month Stock Chart
NBIX 1-Year Stock Chart
NBIX 2-Year Stock Chart
NBIX 5-Year Stock Chart
View Interactive NBIX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Neurocrine Biosciences, Inc..
Current Price: $42.91
Prev Close: $45.05
Open: $44.70
Bid: $42.91
Ask: $47.37
Day's Range: $42.67 - $45.00
52wk Range: $31.25 - $58.46
Volume: 961,222
Avg Vol 1,049,132
Market Cap: $3.70B
P/E (ttm): -42.90
EPS (ttm): -$1.05
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Neurocrine Biosciences, Inc..
CAPS Rating 3 out of 5
 
316 Outperform
49 Underperform
CAPS All Stars
 
89 Outperform
7 Underperform

How do you think Neurocrine Biosciences, Inc. will perform against the market?



You pick for Neurocrine Biosciences, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Kevin C. Gorman, CEO

81% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Neurocrine Biosciences, Inc..

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers